查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2014719

人工髖關節置換市場：依手術入路、固定方式、材料組合、手術類型及最終用戶分類－2026年至2032年全球市場預測

Hip Replacement Implant Market by Surgical Approach, Fixation Method, Material Pairing, Procedure Type, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025年人工髖關節置換術植入市值為75.6億美元，預計到2026年將成長至81.6億美元，複合年成長率為8.92%，到2032年將達到137.5億美元。

主要市場統計數據
基準年 2025 75.6億美元
預計年份：2026年 81.6億美元
預測年份 2032 137.5億美元
複合年成長率 (%) 8.92%

為高階主管提供人工髖關節置換植入領域的策略性展望，整合臨床因素、技術進步和採購實際情況。

髖置換術仍然是肌肉骨骼醫學領域最具影響力的治療方法之一，這主要受人口結構變化、慢性疾病負擔加重以及患者對治療效果和康復速度日益成長的期望所驅動。植入材料和固定技術的進步，以及手術技術的創新，正在為各類患者拓展治療選擇。同時，醫療服務模式正在將手術從住院病房轉移到門診。此外，保險公司和醫療服務提供者也越來越注重醫療價值，這使得臨床證據與購買決策之間的連結更加緊密。

臨床、技術和供應方面的變化都在共同​​作用，重新定義髖關節植入創新如何轉化為醫療服務提供者的採納和商業性價值。

人工髖關節置換領域正經歷快速變革時期，這得益於材料和技術的不斷改進，以及顛覆性數位技術的湧現。材料科學的進步，特別是陶瓷複合材料、高交聯聚乙烯和表面塗層等方面的創新，不斷擴展現代關節軸承的性能極限，同時也改變了外科醫生的選擇偏好和重新置換手術的趨勢。手術技術也在不斷發展。隨著醫療機構對更短復健時間和更短住院時間的需求日益成長，微創手術和組織保留入路變得越來越普遍。影像技術的進步、術中導航技術的改進以及機器人技術的引入，共同促進了這些臨床變革，提高了植入的精確度和可重複性。

2025 年美國關稅措施對髖關節植入技術的採購、定價策略和臨床應用的影響。

美國將於2025年實施新的關稅，這標誌著全球髖植入供應趨勢和籌資策略的重大轉折點。關稅提高了進口零件和成品的成本，迫使製造商和經銷商重新評估其採購地點和合約結構。為此，許多供應商正在加快近岸外包的步伐，將關鍵製造流程轉移到不受關稅影響的地區，並調整零件採購結構以最大限度地降低關稅風險。除了這些營運方面的應對措施外，供應商還在與醫療系統重新談判，要求提高價格透明度並建立風險分擔機制，以降低不斷上漲的採購成本。

以細分市場為中心的智慧分析，揭示了不同維度的臨床需求差異、對醫療設備性能的期望以及採購因素，包括手術、固定方法、材料、程序和最終用戶。

詳細的市場細分和分析揭示了臨床需求、操作可行性和商業性機會之間的交集。手術方法分為微創和傳統兩種。微創方法又分為前路微創和後外側微創，而傳統方法則分為前路和後路。每種方法都有其獨特的器械需求、植入形狀和手術全期方案，這些都會影響外科醫生的選擇和醫院的庫存決策。例如，微創前路手術傾向於選擇能夠保留肌肉並促進早期康復的植入和器械，而傳統後路手術則可能傾向於選擇具有成熟長期治療效果數據且與現有器械相容性強的植入。

影響美洲、歐洲、中東和非洲以及亞太地區監管策略、採購重點和實施路徑的區域比較趨勢。

區域趨勢對產品採納曲線、監管路徑和商業性重點有顯著影響，從而塑造出獨特的市場進入和擴張策略。在美洲，成熟的健保體系和較高的門診手術中心普及率正在加速人們對能夠縮短住院時間和加快康復進程的植入的興趣。此外，該地區高度重視可靠的長期療效數據和註冊登記，這增強了臨床醫生和支付方對成熟技術的信心。美洲的監管機構參與和支付方談判通常優先考慮真實世界數據和基於價值的契約，以確保產品採納與財務課責。

競爭與供應商策略結合產品創新、臨床證據產生和服務主導差異化，以在價值驅動的環境中取得成功。

供應商生態系統持續演變，成熟企業不斷完善產品線，新興企業透過材料創新、模組化架構或服務主導提案，確立自身在細分市場的地位。競爭優勢日益依賴臨床證據、對外科醫生的培訓和支持，以及涵蓋植入物以外的整合式植入體系，該體系還包括手術器械、數位化規劃工具和售後服務。整個產業普遍採取的策略措施包括：垂直整合以確保關鍵零件的供應；與機器人和導航系統開發商建立選擇性合作夥伴關係；以及投資臨床註冊專案以支持其安全性和有效性聲明。

在臨床和政策變革的背景下，製造商、供應商和經銷商必須採取切實可行的、優先的措施來增強韌性、加快部署並創造價值。

產業領導者應採取多管齊下的策略，將產品創新、業務永續營運和與保險公司的合作結合。首先，將生產和供應商關係多元化，以降低貿易政策波動帶來的風險，並確保向大批量生產設施提供不間斷的供應。建立區域生產系統並確保關鍵部件的多個來源，將有助於在保持業務連續性的同時，實現成本可預測性。其次，優先投資微創平台和模組化植入系統，以滿足日益成長的更快康復和多樣化再次手術方案的需求。透過在產品上市的同時實施全面的外科醫生培訓、術中規劃工具和結果追蹤，縮短引進週期並積累真實世界的臨床證據。

收集一手和二手證據以支持對經營團隊的建議，採用三角測量法，並提高品管調查方法。

本分析基於嚴謹的混合研究設計，結合了與關鍵相關人員的對話以及全面的二手證據。主要數據包括對骨科醫生、醫院採購經理、門診手術中心管理人員、監管專家和高級銷售主管的結構化訪談，旨在收集關於臨床偏好、採購趨勢和營運挑戰的第一手觀點。除這些定性研究結果外，本研究還查閱了同行評審的臨床文獻、醫療設備註冊資訊、監管申報文件和操作指南，檢驗有關技術性能和長期安全性徵兆的說法。

為了將創新轉化為可衡量的臨床和商業性成果，高階主管必須整合策略重點和風險因素。

人口結構變化、材料和手術技術的創新，以及醫療服務模式的轉型，共同將人工髖關節市場推向了轉折點，戰略遠見將在此得到回報。臨床進步和數位技術的應用為改善患者預後和提升營運效率創造了機遇，但也為實證醫學的取得、供應鏈的靈活性以及與保險公司的商業性合作帶來了挑戰。關稅帶來的成本壓力和區域法規的複雜性進一步凸顯了建構適應性強的生產系統和積極主動地遵守貿易法規的必要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：全髖關節置換市場：依手術方式分類

  • 微創
    • 前路入路（微創）
    • 後外側微創
  • 傳統方法
    • 前進方向
    • 後方進場

第9章：人工髖關節置換市場：以固定方式分類

  • 水泥固定型
  • 無水泥
  • 混合

第10章：人工髖關節置換市場：依材料組合分類

  • 陶瓷與陶瓷
    • 氧化鋁與氧化鋁
    • 氧化鋯與氧化鋯
  • 陶瓷與聚乙烯
    • 氧化鋁與聚乙烯
    • 氧化鋯與聚乙烯
  • 金屬與金屬
    • 鈷鉻合金與鈷鉻合金
    • 鈦與鈦
  • 金屬與聚乙烯
    • 鈷鉻合金與聚乙烯
    • 鈦與聚乙烯

第11章：髖關節置換市集：依手術類型分類

  • 首次置換術
    • 雙方
    • 一邊
  • 重新置換
    • 髀臼重新置換手術
    • 大型重新置換手術
    • 股骨重新置換

第12章：人工髖關節置換市場：依最終用戶分類

  • 門診手術中心
  • 醫院

第13章：髖關節置換市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：髖關節置換市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：髖關節置換市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國髖關節置換市場

第17章：中國髖關節置換市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AK Medical Holdings Limited
  • Arthrex, Inc.
  • B. Braun Melsungen AG
  • ConMed Corporation
  • Corin Group Ltd
  • DJO Global, Inc.
  • Exactech, Inc.
  • Globus Medical, Inc.
  • Johnson & Johnson
  • Kyocera Corporation
  • LimaCorporate SpA
  • Mathys Ltd Bettlach
  • Medacta International SA
  • MicroPort Scientific Corporation
  • Smith & Nephew plc
  • Stryker Corporation
  • Waldemar Link GmbH & Co. KG
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-437E9896A56D

The Hip Replacement Implant Market was valued at USD 7.56 billion in 2025 and is projected to grow to USD 8.16 billion in 2026, with a CAGR of 8.92%, reaching USD 13.75 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 7.56 billion
Estimated Year [2026] USD 8.16 billion
Forecast Year [2032] USD 13.75 billion
CAGR (%) 8.92%

A strategic orientation to the hip replacement implant sector that synthesizes clinical drivers, technological advances, and procurement realities for executives

Hip arthroplasty continues to be one of the most impactful interventions in musculoskeletal care, driven by demographic shifts, rising chronic disease burden, and evolving expectations for patient outcomes and recovery speed. Advances in implant materials and fixation techniques are converging with surgical innovation to expand treatment options for heterogeneous patient profiles, while healthcare delivery models are migrating procedures from inpatient wards to ambulatory settings. At the same time, payers and providers are imposing greater scrutiny on value, leading to a tighter coupling between clinical evidence and purchasing decisions.

Clinicians and procurement leaders are navigating a complex matrix of trade-offs that include longevity, wear performance, intraoperative efficiency, and total episode cost. Technology adoption is not monolithic; geographical and institutional differences shape uptake of robotics, navigation, and minimally invasive techniques. Regulatory frameworks and post-market surveillance expectations are also rising, creating a premium for robust clinical data and longitudinal outcomes. These forces collectively demand that manufacturers, health systems, and distributors adopt more integrated strategies that connect product development with payer engagement and provider training, ensuring that innovations translate into measurable improvements in clinical and economic outcomes.

This executive summary frames the critical dynamics that will influence competitive positioning over the near to medium term. It emphasizes the need for coordinated action across R&D, market access, and operations to respond to shifting demand patterns while sustaining regulatory compliance and clinician trust.

Compounding clinical, technological, and supply-side shifts that are redefining how hip implant innovation translates into provider adoption and commercial value

The hip implant landscape is undergoing a period of accelerated transformation as incremental improvements in materials and technique compound with disruptive digital capabilities. Material science progress-driven by innovations in ceramic composites, highly crosslinked polyethylene, and surface coatings-has extended the performance envelope of modern bearings while simultaneously altering surgeon preferences and revision profiles. Surgical technique is also evolving; minimally invasive approaches and tissue-sparing access routes are becoming more prevalent as providers seek faster recovery times and reduced length of stay. These clinical shifts have been catalyzed by enhanced imaging, intraoperative guidance, and adoption of robotics, which collectively improve implant positioning and reproducibility.

Concurrently, care delivery is adjusting to financial and logistical pressures. The expansion of ambulatory surgical centers has changed the calculus for device selection, with a premium on implants that enable predictable operative times and straightforward inventory management. Supply chain resilience has come into sharper focus, prompting OEMs to diversify sourcing and hold strategic inventories to guard against disruptions. Reimbursement models are increasingly oriented toward episode-based payments, incentivizing devices and care pathways that reduce readmissions and revisions. As a result, commercial strategies are adapting to emphasize outcome evidence, surgeon training programs, and post-market surveillance.

Taken together, these transformative shifts reinforce a cross-functional imperative: success in this sector requires integrated investments in clinical evidence generation, digital enablement for surgeons, and operational mechanisms that align product value with evolving care delivery models.

Operational and strategic implications of the 2025 United States tariff measures on sourcing, pricing strategies, and clinical access to hip implant technologies

The imposition of new tariffs by the United States in 2025 has introduced a significant inflection point for global hip implant supply dynamics and procurement strategies. Tariff measures increase landed costs for imported components and finished devices, prompting manufacturers and distributors to reassess sourcing footprints and contract structures. In response, many suppliers accelerate nearshoring initiatives, migrate critical manufacturing steps to tariff-safe jurisdictions, or reconfigure component sourcing to minimize customs exposure. These operational responses are complemented by contract renegotiations with health systems that seek greater price transparency and shared risk arrangements to mitigate increased procurement costs.

Hospitals and ambulatory centers confront trade-offs between continuity of care and cost containment. Some institutions preserve existing supplier relationships but push for volume discounts, extended warranties, or consignment models to manage working capital. Others diversify their supplier base to include domestic manufacturers or alternative material pairings that yield favorable pricing without compromising clinical outcomes. Importantly, the tariff environment has placed a premium on supply-chain visibility and classification accuracy, as tariff codes and product categorizations materially affect duty burdens.

From a strategic perspective, suppliers with flexible manufacturing footprints, vertically integrated capabilities, and established regulatory dossiers are better positioned to absorb or offset tariff-driven cost pressures. Forward-looking organizations invest in long-term supplier diversification, invest in customs and trade compliance capabilities, and collaborate with payers and providers to structure value-based purchasing arrangements that share the downside of short-term cost shocks while preserving access to clinically preferred solutions.

Segment-centric intelligence revealing differentiated clinical needs, device performance expectations, and procurement drivers across surgical, fixation, material, procedure, and end-user dimensions

Analyzing the market through detailed segmentation illuminates where clinical need, operational feasibility, and commercial opportunity intersect. Surgical approach divides into minimally invasive and traditional pathways, with the minimally invasive category further distinguishing anterior minimal and posterolateral minimal techniques, and the traditional category distinguishing anterior and posterior approaches. Each pathway introduces unique instrumentation needs, implant geometries, and perioperative protocols that influence surgeon preference and hospital inventory decisions. Minimally invasive anterior techniques, for example, often prioritize implants and instruments that facilitate muscle-sparing access and quicker rehabilitation, whereas traditional posterior approaches may favor implants with established long-term outcome data and broader compatibility with legacy instrumentation.

Fixation method segmentation-cemented, cementless, and hybrid-creates differentiated value propositions for distinct patient cohorts. Cementless systems emphasize osseointegration and modularity, often paired with advanced surface treatments to promote bone in-growth, whereas cemented options remain relevant for specific anatomical or bone-quality considerations. Material pairing segmentation spans ceramic on ceramic, ceramic on polyethylene, metal on metal, and metal on polyethylene configurations. Ceramic on ceramic further divides into alumina on alumina and zirconia on zirconia variants, while ceramic on polyethylene differentiates alumina on polyethylene and zirconia on polyethylene. Metal on metal and metal on polyethylene combinations are similarly subdivided by cobalt chrome or titanium pairings against matching or polyethylene counterparts. These material permutations affect wear behavior, squeaking risk, imaging artifact profiles, and revision strategies, influencing both clinician selection and procurement negotiations.

Procedure type segmentation separates primary from revision procedures, with the primary category subdivided into bilateral and unilateral cases and the revision category differentiated into acetabular, dual, and femoral revisions. The technical complexity, inventory requirements, and cost implications vary substantially across these procedure types, with revision cases typically necessitating expanded modularity and more specialized implants. End-user segmentation between ambulatory surgical centers and hospitals drives divergent purchasing criteria; ambulatory settings prioritize implants that support rapid throughput and predictable outcomes, while hospitals weigh broader case-mix flexibility and long-term registry data more heavily. Integrating these segmentation lenses reveals targeted pathways for product development, clinical education, and reimbursement engagement that align with each segment's distinct clinical and operational priorities.

Comparative regional dynamics that influence regulatory strategy, procurement priorities, and adoption pathways across the Americas, EMEA, and Asia-Pacific

Regional dynamics shape adoption curves, regulatory pathways, and commercial priorities in meaningful ways, creating distinct playbooks for market entry and expansion. In the Americas, a mature reimbursement ecosystem and a high penetration of ambulatory surgical centers accelerate interest in implants that reduce length of stay and support rapid recovery protocols. This region also places a strong emphasis on robust longitudinal outcomes and registries, which reinforce clinician and payer confidence in proven technologies. Regulatory engagement and payer negotiations in the Americas often prioritize real-world evidence and value-based contracting to align product adoption with fiscal accountability.

Across Europe, the Middle East & Africa, heterogeneous regulatory regimes and varying reimbursement frameworks necessitate region-specific strategies. Several European markets maintain centralized procurement mechanisms and comparative effectiveness evaluations that favor cost-effective solutions with strong clinical evidence. Middle Eastern markets are increasingly receptive to premium technologies when bundled with training and service commitments, while many African markets prioritize affordability and supply reliability. Vendors must therefore calibrate offerings to local procurement norms and invest in targeted clinical and commercial support to overcome market fragmentation.

The Asia-Pacific region is characterized by rapid volume growth, expanding surgical capacity, and divergent maturity across national health systems. Certain countries lead in local manufacturing capabilities and innovation adoption, while others are still building procedural capacity and registry infrastructure. Cost-sensitive procurement coexists with pockets of rapid adoption for advanced materials and digital surgical tools, driven by rising clinician expertise and expanding private-sector surgical facilities. These regional contrasts underscore the need for differentiated go-to-market strategies that account for regulatory complexity, local manufacturing potential, and the balance between premium and cost-effective product tiers.

Competitive dynamics and supplier playbooks that combine product innovation, clinical evidence generation, and service-led differentiation to win in a value-focused environment

The supplier ecosystem continues to evolve, with incumbents refining product breadth and emerging players carving niche positions through material innovation, modular architectures, or service-led propositions. Competitive differentiation increasingly hinges on a combination of clinical evidence, surgeon training and support, and integrated offerings that extend beyond the implant itself to include instrumentation, digital planning tools, and aftermarket services. Strategic behaviors observed across the sector include vertical integration to secure critical component supply, selective partnerships with robotics and navigation developers, and investment in clinical registry programs to reinforce safety and effectiveness claims.

Commercial models are also diversifying. Some suppliers emphasize bundled solutions and episode-based pricing, collaborating directly with providers and payers to align incentives around outcomes. Others prioritize high-touch surgeon engagement through education centers, cadaver labs, and proctoring programs to accelerate technique adoption. Distribution and logistics capabilities are a differentiator as well, particularly in regions where supply-chain reliability influences purchasing decisions. Organizations that offer predictable service levels, flexible consignment arrangements, and responsive clinical support gain a competitive edge in procurement discussions.

Success for market participants depends on balancing near-term commercial wins with long-term investments in evidence generation and clinician partnerships. Firms that combine product performance with operational excellence and demonstrable outcomes are better placed to influence formularies and secure sustained preferential use.

Practical and prioritized actions for manufacturers, providers, and distributors to strengthen resilience, accelerate adoption, and capture value amid clinical and policy shifts

Industry leaders should adopt a multi-dimensional strategy that aligns product innovation with operational resilience and payer engagement. First, diversify manufacturing and supplier relationships to reduce exposure to trade-policy volatility and ensure uninterrupted supply to high-volume centers. Establishing regional production capabilities or multi-sourcing for critical components will preserve continuity while delivering cost predictability. Second, prioritize investments in minimally invasive platforms and modular implant systems that address growing demand for faster recovery and versatile revision options. Complement product launches with comprehensive surgeon training, intraoperative planning tools, and outcomes tracking to shorten adoption cycles and build real-world evidence.

Third, engage payers proactively to develop value-based arrangements that reward outcomes and cost containment. Structure pilot programs that demonstrate reductions in length of stay, readmission rates, and revision incidence, and leverage these results to negotiate preferred-product pathways. Fourth, optimize commercial models for ambulatory surgical centers by tailoring bundles that support higher throughput, simplified instrumentation, and just-in-time supply. Fifth, enhance post-market surveillance and data analytics capabilities to detect performance trends early and to support regulatory submissions and tender processes. Finally, scenario-plan for regulatory and trade-policy changes by investing in customs expertise, tariff classification accuracy, and flexible logistics to maintain competitiveness under shifting external conditions.

Implementing these actions requires cross-functional coordination across R&D, supply chain, clinical affairs, and commercial teams, ensuring that investments in product and process translate into measurable improvements in clinical outcomes and financial performance.

Methodological transparency describing primary and secondary evidence collection, triangulation techniques, and quality controls that underpin the executive findings

The analysis draws on a rigorous mixed-methods research design combining primary stakeholder engagement with comprehensive secondary evidence synthesis. Primary inputs include structured interviews with orthopedic surgeons, hospital procurement leaders, ambulatory surgical center administrators, regulatory specialists, and senior commercial executives to capture firsthand perspectives on clinical preferences, purchasing dynamics, and operational challenges. These qualitative insights are complemented by a review of peer-reviewed clinical literature, device registries, regulatory filings, and procedural guidelines to validate technical performance claims and long-term safety signals.

Secondary research encompassed public policy documents, trade data, and clinical practice recommendations to model the interaction between regulatory changes, tariff effects, and adoption patterns. Data triangulation was applied to reconcile divergent viewpoints and to ensure that conclusions are grounded in multiple independent sources. Quality assurance procedures included cross-validation of interview transcripts, methodological audits of evidence selection, and internal peer review by clinical and market-access experts. Limitations were acknowledged where evidence gaps exist, particularly in newer material pairings and emerging minimally invasive techniques that lack long-duration outcome data.

Overall, the methodology balanced depth of clinical insight with breadth of commercial intelligence, enabling robust, actionable conclusions while transparently documenting assumptions and evidence sources.

Synthesis of strategic priorities and risk considerations that executives must align to convert innovation into measurable clinical and commercial outcomes

The convergence of demographic demand, materials and surgical innovation, and shifting care-delivery models positions the hip implant sector at an inflection point that rewards strategic foresight. Clinical advances and digital enablement create opportunities to improve patient outcomes and operational efficiency, but they also raise the bar for evidence generation, supply-chain agility, and commercial alignment with payers. Tariff-related cost pressures and regional regulatory complexity further emphasize the need for adaptable manufacturing footprints and proactive trade compliance.

Stakeholders that integrate clinical, commercial, and operational strategies will be best positioned to capture sustained value. This requires prioritizing robust clinical evidence, investing in surgeon training and digital planning tools, diversifying supply chains, and engaging payers in value-based arrangements. By applying these principles, manufacturers can not only protect margins but also expand access through demonstrable outcomes and flexible commercial models, while providers can optimize care pathways that deliver improved recovery and cost-effectiveness.

Taken together, the sector's near-term trajectory will be determined by the speed at which organizations translate innovation into validated clinical benefit and operational reliability, making coordinated cross-functional execution the defining capability for success.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Hip Replacement Implant Market, by Surgical Approach

  • 8.1. Minimally Invasive
    • 8.1.1. Anterior Minimal
    • 8.1.2. Posterolateral Minimal
  • 8.2. Traditional
    • 8.2.1. Anterior Approach
    • 8.2.2. Posterior Approach

9. Hip Replacement Implant Market, by Fixation Method

  • 9.1. Cemented
  • 9.2. Cementless
  • 9.3. Hybrid

10. Hip Replacement Implant Market, by Material Pairing

  • 10.1. Ceramic on Ceramic
    • 10.1.1. Alumina on Alumina
    • 10.1.2. Zirconia on Zirconia
  • 10.2. Ceramic on Polyethylene
    • 10.2.1. Alumina on Polyethylene
    • 10.2.2. Zirconia on Polyethylene
  • 10.3. Metal on Metal
    • 10.3.1. Cobalt Chrome on Cobalt Chrome
    • 10.3.2. Titanium on Titanium
  • 10.4. Metal on Polyethylene
    • 10.4.1. Cobalt Chrome on Polyethylene
    • 10.4.2. Titanium on Polyethylene

11. Hip Replacement Implant Market, by Procedure Type

  • 11.1. Primary
    • 11.1.1. Bilateral
    • 11.1.2. Unilateral
  • 11.2. Revision
    • 11.2.1. Acetabular Revision
    • 11.2.2. Dual Revision
    • 11.2.3. Femoral Revision

12. Hip Replacement Implant Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals

13. Hip Replacement Implant Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Hip Replacement Implant Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Hip Replacement Implant Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Hip Replacement Implant Market

17. China Hip Replacement Implant Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. AK Medical Holdings Limited
  • 18.6. Arthrex, Inc.
  • 18.7. B. Braun Melsungen AG
  • 18.8. ConMed Corporation
  • 18.9. Corin Group Ltd
  • 18.10. DJO Global, Inc.
  • 18.11. Exactech, Inc.
  • 18.12. Globus Medical, Inc.
  • 18.13. Johnson & Johnson
  • 18.14. Kyocera Corporation
  • 18.15. LimaCorporate S.p.A.
  • 18.16. Mathys Ltd Bettlach
  • 18.17. Medacta International S.A.
  • 18.18. MicroPort Scientific Corporation
  • 18.19. Smith & Nephew plc
  • 18.20. Stryker Corporation
  • 18.21. Waldemar Link GmbH & Co. KG
  • 18.22. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HIP REPLACEMENT IMPLANT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HIP REPLACEMENT IMPLANT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES HIP REPLACEMENT IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA HIP REPLACEMENT IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR MINIMAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR MINIMAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR MINIMAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTEROLATERAL MINIMAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTEROLATERAL MINIMAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTEROLATERAL MINIMAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR APPROACH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR APPROACH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ANTERIOR APPROACH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTERIOR APPROACH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTERIOR APPROACH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY POSTERIOR APPROACH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTLESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTLESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CEMENTLESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HYBRID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HYBRID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HYBRID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON ALUMINA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON ALUMINA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON ALUMINA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON ZIRCONIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON ZIRCONIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON ZIRCONIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ALUMINA ON POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ZIRCONIA ON POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON COBALT CHROME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON COBALT CHROME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON COBALT CHROME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COBALT CHROME ON POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY TITANIUM ON POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY BILATERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY BILATERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY BILATERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY UNILATERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY UNILATERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY UNILATERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ACETABULAR REVISION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ACETABULAR REVISION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY ACETABULAR REVISION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY DUAL REVISION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY DUAL REVISION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY DUAL REVISION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FEMORAL REVISION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FEMORAL REVISION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY FEMORAL REVISION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2018-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2018-2032 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2018-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. GCC HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 234. GCC HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 235. GCC HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 236. GCC HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2018-2032 (USD MILLION)
  • TABLE 237. GCC HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 238. GCC HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2018-2032 (USD MILLION)
  • TABLE 239. GCC HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2018-2032 (USD MILLION)
  • TABLE 240. GCC HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 241. GCC HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2018-2032 (USD MILLION)
  • TABLE 242. GCC HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 243. GCC HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. GCC HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2018-2032 (USD MILLION)
  • TABLE 245. GCC HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2018-2032 (USD MILLION)
  • TABLE 246. GCC HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPEAN UNION HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. BRICS HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 263. BRICS HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2018-2032 (USD MILLION)
  • TABLE 265. BRICS HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 266. BRICS HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 269. BRICS HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. BRICS HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. G7 HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 276. G7 HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 277. G7 HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 278. G7 HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2018-2032 (USD MILLION)
  • TABLE 279. G7 HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 280. G7 HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2018-2032 (USD MILLION)
  • TABLE 281. G7 HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2018-2032 (USD MILLION)
  • TABLE 282. G7 HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 283. G7 HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2018-2032 (USD MILLION)
  • TABLE 284. G7 HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 285. G7 HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. G7 HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2018-2032 (USD MILLION)
  • TABLE 287. G7 HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2018-2032 (USD MILLION)
  • TABLE 288. G7 HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 289. NATO HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 290. NATO HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 291. NATO HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 292. NATO HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2018-2032 (USD MILLION)
  • TABLE 293. NATO HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 294. NATO HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2018-2032 (USD MILLION)
  • TABLE 295. NATO HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2018-2032 (USD MILLION)
  • TABLE 296. NATO HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 297. NATO HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2018-2032 (USD MILLION)
  • TABLE 298. NATO HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 299. NATO HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 300. NATO HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2018-2032 (USD MILLION)
  • TABLE 301. NATO HIP REPLACEMENT IMPLANT MARKET SIZE, BY REVISION, 2018-2032 (USD MILLION)
  • TABLE 302. NATO HIP REPLACEMENT IMPLANT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 303. GLOBAL HIP REPLACEMENT IMPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 304. UNITED STATES HIP REPLACEMENT IMPLANT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED STATES HIP REPLACEMENT IMPLANT MARKET SIZE, BY SURGICAL APPROACH, 2018-2032 (USD MILLION)
  • TABLE 306. UNITED STATES HIP REPLACEMENT IMPLANT MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED STATES HIP REPLACEMENT IMPLANT MARKET SIZE, BY TRADITIONAL, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED STATES HIP REPLACEMENT IMPLANT MARKET SIZE, BY FIXATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED STATES HIP REPLACEMENT IMPLANT MARKET SIZE, BY MATERIAL PAIRING, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED STATES HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON CERAMIC, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED STATES HIP REPLACEMENT IMPLANT MARKET SIZE, BY CERAMIC ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED STATES HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON METAL, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED STATES HIP REPLACEMENT IMPLANT MARKET SIZE, BY METAL ON POLYETHYLENE, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED STATES HIP REPLACEMENT IMPLANT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 315. UNITED STATES HIP REPLACEMENT IMPLANT MARKET SIZE, BY PRIMARY, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED STATES HIP REPLACEM